SG11202102833TA - Engineered microorganisms and methods of making and using same - Google Patents

Engineered microorganisms and methods of making and using same

Info

Publication number
SG11202102833TA
SG11202102833TA SG11202102833TA SG11202102833TA SG11202102833TA SG 11202102833T A SG11202102833T A SG 11202102833TA SG 11202102833T A SG11202102833T A SG 11202102833TA SG 11202102833T A SG11202102833T A SG 11202102833TA SG 11202102833T A SG11202102833T A SG 11202102833TA
Authority
SG
Singapore
Prior art keywords
making
methods
same
engineered microorganisms
engineered
Prior art date
Application number
SG11202102833TA
Other languages
English (en)
Inventor
Gautam Dantas
Suryang Kwak
Herbert Virgin
Original Assignee
Univ Washington
Vir Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington, Vir Biotechnology Inc filed Critical Univ Washington
Publication of SG11202102833TA publication Critical patent/SG11202102833TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
SG11202102833TA 2018-09-20 2019-09-20 Engineered microorganisms and methods of making and using same SG11202102833TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862733896P 2018-09-20 2018-09-20
PCT/US2019/052044 WO2020061389A1 (en) 2018-09-20 2019-09-20 Engineered microorganisms and methods of making and using same

Publications (1)

Publication Number Publication Date
SG11202102833TA true SG11202102833TA (en) 2021-04-29

Family

ID=69887875

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202102833TA SG11202102833TA (en) 2018-09-20 2019-09-20 Engineered microorganisms and methods of making and using same

Country Status (11)

Country Link
US (1) US20220033764A1 (ja)
EP (1) EP3917970A4 (ja)
JP (1) JP2022502081A (ja)
CN (1) CN112888712A (ja)
AU (1) AU2019345157A1 (ja)
CA (1) CA3113642A1 (ja)
EA (1) EA202192317A1 (ja)
IL (1) IL281700A (ja)
MX (1) MX2021003310A (ja)
SG (1) SG11202102833TA (ja)
WO (1) WO2020061389A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113462676B (zh) * 2021-05-26 2023-04-18 百葵锐(天津)生物科技有限公司 一种在细胞表面展示裂解酶的方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2738840B1 (fr) * 1995-09-19 1997-10-31 Rhone Poulenc Rorer Sa Souches de levures genetiquement modifiees
CN100365125C (zh) * 2000-07-26 2008-01-30 韩国生命工学研究院 来源于酵母的新型细胞壁锚定蛋白及其基因和使用其的细胞表面表达系统
US20040170970A1 (en) * 2000-08-04 2004-09-02 Alexander Varshavsky Split- ubiquitin based reporter systems and methods of their use
WO2003029456A1 (en) * 2001-10-01 2003-04-10 Dyax Corp. Multi-chain eukaryotic display vectors and uses thereof
CA2672229A1 (en) * 2006-12-14 2008-06-19 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
WO2008092041A2 (en) * 2007-01-24 2008-07-31 Carnegie Mellon University Optical biosensors
EP2273998A2 (en) * 2008-04-04 2011-01-19 Farallone Holdings Bv Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents
US20120171188A1 (en) * 2008-08-19 2012-07-05 Hyglos Invest Gmbh Artificial Peptidoglycan Lysing Enzymes and Peptidoglycan Binding Proteins
KR102227975B1 (ko) * 2014-07-24 2021-03-15 삼성전자주식회사 방사선 감수성 보완 키나아제의 활성이 증가되도록 유전적으로 조작된, 내산성을 갖는 효모 세포 및 그를 이용하여 락테이트를 생산하는 방법
EP3218477A4 (en) * 2014-11-10 2018-07-18 The Board of Trustees of The Leland Stanford Junior University Compositions and methods for expressing polypeptides on the surface of cells
JP7184336B2 (ja) * 2015-10-13 2022-12-06 ザ ユニバーシティ オブ メリーランド,ボルチモア クロストリジウム・ディフィシル感染症に対する酵母ベースの免疫療法

Also Published As

Publication number Publication date
MX2021003310A (es) 2021-07-15
CN112888712A (zh) 2021-06-01
US20220033764A1 (en) 2022-02-03
WO2020061389A1 (en) 2020-03-26
AU2019345157A1 (en) 2021-12-23
JP2022502081A (ja) 2022-01-11
EP3917970A1 (en) 2021-12-08
EA202192317A1 (ru) 2021-11-15
EP3917970A4 (en) 2023-05-10
IL281700A (en) 2021-05-31
CA3113642A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
EP3612198A4 (en) GENETICALLY PRODUCED COMMENSAL BACTERIA AND METHODS OF USE
EP3500355A4 (en) BIOREACTOR AND METHOD FOR USE THEREOF
SG11202005815UA (en) Bioreactor and related methods
ZA201903518B (en) Imp-producing microorganism and method of producing imp using the same
EP3416592A4 (en) BONE GRAFT AND METHOD FOR MANUFACTURING AND USING SAME
IL272578A (en) Cyclic spiro compounds and methods for their preparation and use
MX2019010984A (es) Composiciones de sintecina y metodos de uso.
EP3635000A4 (en) MANABODIES AND METHODS OF USE
ZA202001208B (en) Spirocycle compounds and methods of making and using same
ZA202005674B (en) Glucoamylases and methods of use thereof
EP3682008A4 (en) GENETICALLY MODIFIED MICRO-ORGANISMS AND THEIR METHODS OF USE
IL288091A (en) Methods for characterizing and using condensed matter-matter interactions
EP3691738A4 (en) IMPLANTABLE BIOREACTOR AND ITS MANUFACTURING AND USE PROCESSES
EP3316828A4 (en) TECHNICAL MATERIALS AND METHOD FOR THE PRODUCTION THEREOF
GB201717885D0 (en) Prothesis and method of manufacture
IL283782A (en) Analosomes and methods of use
IL287106A (en) Engineered productive cell lines and methods for their preparation and use
EP3500546A4 (en) PROPENYLAMINES AND PROCESSES FOR THEIR PREPARATION AND USE
IL276053A (en) Therapeutic Gard and methods of its use
IL281700A (en) Engineered microorganisms and methods of making and using same
EP3810549C0 (en) MODIFIED ACTIVATED CARBON AND METHODS OF USE THEREOF
EP3793552C0 (en) ABHD12 INHIBITORS AND METHODS OF MANUFACTURE AND USE THEREOF
GB2574223B (en) Adhesives and methods of forming adhesives
GB201820842D0 (en) Sercurity documents and methods of manufacture thereof
SG11202001971UA (en) Polyolefin dispersants and methods of making and using thereof